In conclusion, MI supplementation (4 g/day) for 8 weeks along with dietary recommendations, upregulated AMPK, AKT, and PDK‐1 mRNA expression in PBMCs and manifested as improved IR indices in patients with NAFLD. Here, AKT1 is linked to metabolic dysfunction-associated steatotic liver disease.